PUBBLICAZIONI CLINICA METABOLICA
Pubblicazioni 2014
Le seguenti pubblicazioni sono state pubblicate nel corso dell’anno 2014
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients.
Bellasi A, Raggi P, Rossi R, Rochira V, Stentarelli C, Zona S, Lattanzi A, Carli F, Mussini C, Guaraldi G.
Atherosclerosis. 2014 Dec;237(2):618-22. doi: 10.1016/j.atherosclerosis.2014.10.017. Epub 2014 Oct 18.
Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study.
Spagnuolo V, Galli L, Bigoloni A, Nozza S, Monforte Ad, Antinori A, Di Biagio A, Rusconi S, Guaraldi G, Di Giambenedetto S, Lazzarin A, Castagna A.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19806. doi: 10.7448/IAS.17.4.19806. eCollection 2014.
Burden of subclinical heart and lung disease detected on thoracic CT scans of HIV patients on HAART.
Zona S, Santoro A, Besutti G, Ligabue G, Mussini C, Raggi P, Leipsic J, Sin DD, Guaraldi G.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19716. doi: 10.7448/IAS.17.4.19716. eCollection 2014.
CD4/CD8 ratio is not predictive of multi-morbidity prevalence in HIV-infected patients but identify patients with higher CVD risk.
Menozzi M, Zona S, Santoro A, Carli F, Stentarelli C, Mussini C, Guaraldi G.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19709. doi: 10.7448/IAS.17.4.19709. eCollection 2014.
Predictors of emphysema progression in HIV-positive patients.
Guaraldi G, Santoro A, Besutti G, Scaglioni R, Ligabue G, Zona S, Man P, Sin D, Leipsic J, Mussini C.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19660. doi: 10.7448/IAS.17.4.19660. eCollection 2014.
Increased incidence of sexually transmitted diseases in the recent years: data from the ICONA cohort.
Cingolani A, Zona S, Girardi E, Lepri AC, Monno L, Quiros Roldan E, Guaraldi G, Antinori A, Monforte Ad, Marcotullio S; ICONA Foundation Study.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19653. doi: 10.7448/IAS.17.4.19653. eCollection 2014.
Monitoring renal function during combination therapy with telaprevir in HIV/HCV co-infected patients with advanced/fibrosis cirrhosis.
Puzzolante C, Vecchia M, Zona S, Borghi V, Guaraldi G, Mussini C.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19627. doi: 10.7448/IAS.17.4.19627. eCollection 2014.
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.
Armignacco O, Andreoni M, Sagnelli E, Puoti M, Bruno R, Gaeta GB, Perno CF, Santantonio TA, Bonfanti P, Bonora S, Borderi M, Castagna A, d'Arminio Monforte A, De Luca A, Grossi P, Guaraldi G, Maggiolo F, Mussini C, Sagnelli C, Tavio M, Torti C, Uberti-Foppa C, Andreoni M, Angarano G, Antinori A, Armignacco O, Carosi G, Chirianni A, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Sagnelli E, Taliani G.
New Microbiol. 2014 Oct;37(4):423-38. Epub 2014 Oct 1.
The burden of image based emphysema and bronchiolitis in HIV-infected individuals on antiretroviral therapy.
Guaraldi G, Besutti G, Scaglioni R, Santoro A, Zona S, Guido L, Marchioni A, Orlando G, Carli F, Beghe B, Fabbri L, Leipsic J, Sin DD, Man SF.
PLoS One. 2014 Oct 29;9(10):e109027. doi: 10.1371/journal.pone.0109027. eCollection 2014.
Hypogonadism in the HIV-infected man.
Rochira V, Guaraldi G.
Endocrinol Metab Clin North Am. 2014 Sep;43(3):709-30. doi: 10.1016/j.ecl.2014.06.005. Review.
Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients.
Bucciardini R, Pugliese K, Weimer L, Digregorio M, Fragola V, Mancini M, Maroccia Z, Ladisa N, Francisci D, Bellagamba R, Degli Antoni A, Guaraldi G, Cirioni O, Ortu F, Parruti G, Mannazzu M, Libertone R, Donnini S, Floridia M; ISS-NIA Study Group.
HIV Clin Trials. 2014 Jul-Aug;15(4):176-83. doi: 10.1310/hct1504-176.
Impact of antiretroviral medications on fasting lipid parameters.
Guaraldi G, Santoro A, Stentarelli C, Luzi K.
Rev Cardiovasc Med. 2014;15 Suppl 1:S30-7. Review.
Frailty in people aging with human immunodeficiency virus (HIV) infection.
Brothers TD, Kirkland S, Guaraldi G, Falutz J, Theou O, Johnston BL, Rockwood K.
J Infect Dis. 2014 Oct 15;210(8):1170-9. doi: 10.1093/infdis/jiu258. Epub 2014 Jun 5.
Multimorbidity and functional status assessment.
Guaraldi G, Silva AR, Stentarelli C.
Curr Opin HIV AIDS. 2014 Jul;9(4):386-97. doi: 10.1097/COH.0000000000000079. Review.
Morbidity in older HIV-infected patients: impact of long-term antiretroviral use.
Guaraldi G, Prakash M, Moecklinghoff C, Stellbrink HJ.
AIDS Rev. 2014 Apr-Jun;16(2):75-89. Review.
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection.
Guaraldi G, Stentarelli C, Zona S, Santoro A, Beghetto B, Carli F, Orlando G, Franceschetto A, Casolo A, Mussini C.
HIV Med. 2014 Nov;15(10):587-94. doi: 10.1111/hiv.12159. Epub 2014 Apr 21.
[Inhibition of the renin-angiotensin system in HIV nephropathy].
Guaraldi G, Dolci G, Bellasi A, Di Iorio B.
G Ital Nefrol. 2014 Jan-Feb;31(1). pii: gin/31.1.14. Italian.
Metabolic alterations in HIV-infected pregnant women: moving to metabolic tailoring of antiretroviral drugs.
Guaraldi G, Stentarelli C, Da Silva AD, Luzi K, Neri I, Cellini M, Petrella E, Garlassi E, Menozzi M, Facchinetti F, Mussini C.
AIDS Rev. 2014 Jan-Mar;16(1):14-22. Review.
Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution.
Brigante G, Diazzi C, Ansaloni A, Zirilli L, Orlando G, Guaraldi G, Rochira V.
Eur J Endocrinol. 2014 Apr 10;170(5):685-96. doi: 10.1530/EJE-13-0961. Print 2014 May.
Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy.
Guaraldi G, Cossarizza A, Franceschi C, Roverato A, Vaccher E, Tambussi G, Garlassi E, Menozzi M, Mussini C, Dʼarminio Monforte A.
J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):175-81. doi: 10.1097/QAI.0000000000000018.
Male sexual dysfunction and HIV--a clinical perspective.
Santi D, Brigante G, Zona S, Guaraldi G, Rochira V.
Nat Rev Urol. 2014 Feb;11(2):99-109. doi: 10.1038/nrurol.2013.314. Epub 2014 Jan 7. Review.
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trial.
Guaraldi G, Zona S, Cossarizza A, Vernacotola L, Carli F, Lattanzi A, Nardini G, Orlando G, Garlassi E, Termini R, Garau M.
Int J STD AIDS. 2014 Mar;25(3):207-12. doi: 10.1177/0956462413497701. Epub 2013 Aug 28.
Surrogate markers of visceral adipose tissue in treated HIV-infected patients: accuracy of waist circumference determination.
Falutz J, Rosenthall L, Kotler D, Zona S, Guaraldi G.
HIV Med. 2014 Feb;15(2):98-107. doi: 10.1111/hiv.12085. Epub 2013 Sep 22.
Urolithiasis associated with atazanavir may mask a metabolic 'channelling' bias.
Guaraldi G, Dolci G, Bellasi A.
J Antimicrob Chemother. 2014 Jan;69(1):284-5. doi: 10.1093/jac/dkt306. Epub 2013 Aug 9. No abstract available.
TUTTE LE NOSTRE PUBBLICAZIONI
Siamo lieti
di accoglierti
Chiedici informazioni
o prenota la tua prima visita
presso la Clinica Metabolica
di Modena